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Abstract
Objective
To evaluate the effect of preoperative anaemia and blood transfusion on 30-day postopera-
tive morbidity and mortality in patients undergoing gynecological surgery.
Study Design
Data were analyzed from 12,836 women undergoing operation in the American College of
Surgeons National Surgical Quality Improvement Program. Outcomes measured were; 30-
day postoperative mortality, composite and specific morbidities (cardiac, respiratory, central
nervous system, renal, wound, sepsis, venous thrombosis, or major bleeding). Multivariate
logistic regression models were performed using adjusted odds ratios (ORadj) to assess
the independent effects of preoperative anaemia (hematocrit <36.0%) on outcomes, effect
estimates were performed before and after adjustment for perioperative transfusion
requirement.
Results
The prevalence of preoperative anaemia was 23.9% (95%CI: 23.2–24.7). Adjusted for con-
founders by multivariate logistic regression; preoperative anaemia was independently and
significantly associated with increased odds of 30-day mortality (OR: 2.40, 95%CI: 1.06–
5.44) and composite morbidity (OR: 1.80, 95%CI: 1.45–2.24). This was reflected by signifi-
cantly higher adjusted odds of almost all specific morbidities including; respiratory, central
nervous system, renal, wound, sepsis, and venous thrombosis. Blood Transfusion
increased the effect of preoperative anaemia on outcomes (61% of the effect on mortality
and 16% of the composite morbidity).
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Conclusions
Preoperative anaemia is associated with adverse post-operative outcomes in women
undergoing gynecological surgery. This risk associated with preoperative anaemia did not
appear to be corrected by use of perioperative transfusion.
Introduction
Preoperative anaemia is an emerging concern in patients undergoing surgery. This has been
also been attributed to the increased need for perioperative transfusions in the anaemic subject
[1–4], which are also independently associated with adverse postoperative outcomes even
when as low as one unit of packed red blood cells (pRBC) is administered intraoperatively [5–
9]. More recently, it has also been established that preoperative anaemia carries an increased
risk of longer hospital stay and increased postoperative morbidity and mortality, irrespective of
the need for transfusion therapy [10–18]. However, available data mostly come from large ret-
rospective studies reporting overall outcomes for a heterogeneous mix of patients undergoing
general, vascular, or orthopaedic procedures; often with older patients with concomitant mor-
bidities [12]. Consequently, anaemia may be a marker of the older and more ‘high risk’ patient.
The impact and effect of preoperative anaemia in a more homogenous and younger age group
of patients undergoing surgery, less likely to have comorbidities’ is not known.
A major cause of uterine surgery in reproductive age women is uterine fibroids. Fibroids are
found in up to 70–80% of women and may cause a number of symptoms requiring surgery
[19]. Heavy menstrual bleeding is a common symptom and is probably the most frequent
cause of anaemia in young-otherwise healthy women. Hysterectomy is the most common oper-
ation carried out in women with fibroids, followed by myomectomy, and these are more likely
to be performed in women with symptomatic fibroids [20]. Similarly, anaemia may be a com-
mon complication of the disease or its treatment in women with gynaecologic malignancies,
which may require surgical intervention along the course of disease management. Hence,
women undergoing uterine surgery may often be anaemic preoperatively and are likely to be
younger and relatively free of significant cardiovascular or respiratory comorbidities.
In order to address this research gap, we used data from the American College of Surgeons
National Surgical Quality Improvement Program (ACS NSQIP) to determine the effects of pre-
operative anaemia on morbidity and mortality in women undergoing uterine surgery. We also
evaluated if such effects are independent or mostly mediated by an increased requirement for
perioperative transfusions.
Materials and Methods
Study design and sample
This is retrospective cohort study using data from the ACS NSQIP database. Details of the ACS
NSQIP (www.acsnsqip.org) have been recently described [12] and are summarized in supple-
mentary S1 Table. It is a validated outcomes registry designed to provide feedback to partici-
pating hospitals on 30-day risk-adjusted surgical mortality and morbidity [21,22]. The
database includes de-identified data on demographics, perioperative variables, and 30-day
postoperative outcomes for adult patients undergoing major surgery in participating nonveter-
an’s administration hospitals [21]. Trained surgical clinical reviewers collect patient data upon
admission from the medical chart, operative log, anaesthesia record, interviews with the
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attending surgeon, and telephone interviews with the patient [21]. Data quality is ensured
through comprehensive training of the nurse reviewers, an inter-rater reliability audit of partic-
ipating sites, regular conference calls, and an annual meeting [23]. For this study, the available
ACS NSQIP Participant Use Files of the years 2008 (271,368 cases from 211 sites) and 2009
(336,190 cases from 237 sites) were retrieved for all major surgeries performed at participating
ACS NSQIP Medical Centres located in the US, Canada, Lebanon and the United Arab Emir-
ates. In accordance with the American University of Beirut’s guidelines (which follow the US
Code of Federal Regulations for the Protection of Human Subjects), institutional review board
approval was not needed or sought for our analysis because data were collected as part of a
quality assurance activity.
We included all women undergoing uterine surgery as identified by the Current Procedural
Terminology (CPT) codes. These were reviewed by two authors and grouped into three catego-
ries:myomectomy (58140, 58145, 58146), simple hysterectomy (58150, 58152, 58180, 58260,
58262, 58263, 58267, 58270, 58275, 58280, 58285, 58290, 58291, 58292, 58293, 58294, 58541,
58542, 58543, 58544, 58550, 58552, 58553, 58554, 58570, 58571, 58572, 58573), and complex
hysterectomy (58200, 58210, 58240, 58548, 58940, 58943, 58950, 58951, 58952, 58953, 58954,
58956, 58957, 58958). For patients having more than one procedure only the index case was
included. We excluded patients with a missing preoperative haematocrit level (n = 527). The
main analysis was conducted on 12,836 patients.
Preoperative anaemia
Retrieved preoperative haematocrit (HCT) level reflected the last HCT measurement prior to
the index operation. Some 99.4% of the HCT levels were obtained within two months of the
index surgery, 97.5% were obtained within one month and 90.3% were obtained within two
weeks. We defined preoperative anaemia as a HCT level<36.0% according to the World
Health Organization’s sex-based criteria [24].
Postoperative outcomes
Evaluated postoperative outcomes were 30-day mortality and morbidity including: (1) cardiac
(acute myocardial infarction or cardiac arrest requiring cardiopulmonary resuscitation); (2)
respiratory (pneumonia, ventilator support for greater than 48 hours, or unplanned intuba-
tion); (3) central nervous system (CNS) (cerebrovascular accident or coma lasting more than
24 hours); (4) renal (progressive renal insufficiency or acute renal failure); (5) wound (deep
incisional surgical site infection, organ or space surgical site infection, or wound dehiscence);
(6) sepsis (sepsis or septic shock); (7) venous thrombosis (deep venous thrombosis or pulmo-
nary embolism); and (8) major bleeding (requiring transfusion of more than four pRBC units
within 72 hours postoperatively) based on the definitions used by ACS NSQIP. Composite
morbidity was defined as having one or more of the aforementioned major morbidities.
Statistical analysis
Bivariate comparisons between the preoperative anaemia and no anaemia groups were done
using the chi-square test for categorical variables and the independent samples t-test for con-
tinuous variables.
The primary study outcome measure was death within 30 days of the index surgery in the
preoperative anaemia compared with the no preoperative anaemia group. The secondary study
outcome measure was occurrence of morbidity (composite and specific morbidities) within 30
days of the index surgery in the preoperative anaemia compared with the no preoperative anae-
mia group. Separate multivariate logistic regression models for 30-day mortality, composite
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morbidity, and each specific morbidity were performed using adjusted odds ratios (ORadj).
Models were built by adjusting the determinant variable (preoperative anaemia vs. no anaemia)
to a priori defined potential confounders of clinical relevance (risk factors that may have
caused both preoperative anaemia as well as adverse 30-day postoperative outcomes) includ-
ing; cancer, bleeding disorder, cardiac disease diabetes etc. (Table 1). Two levels of adjustment
were used, Model 1 (ORadj-1) with basic adjustment for the most clinically relevant variables
and Model 2 (ORadj-2) with extended adjustment for a larger number of clinically relevant risk
factors. Data were near complete, with the exception of missing values for body mass index
(n = 83, 0.7%), which were imputed by the respective means of similar age groups.
To establish whether the effects of preoperative anaemia on 30-day postoperative mortality
and morbidity are mediated by an increased requirement for perioperative transfusions, we
also compared the effect estimates before and after adjustment for perioperative transfusion
requirement.
To determine the potential effect of the excluded 527 patients with no preoperative HCT
values on the observed association between preoperative anaemia and 30-day postoperative
mortality and morbidity, we carried out two separate sensitivity analyses: one including all
Table 1. Patients’ characteristics.
Parameter No preoperative anaemia (n = 9,765) Preoperative anaemia (n = 3,071) p-value
Age in years, mean (SD) 49.0 (12.3) 47.1 (11.3) <0.001
Race, % <0.001
White 76.7 58.5
Black or African American 9.9 26.7
Other/Unknown 13.5 14.9
Uterine surgery, % <0.001
Myomectomy 3.1 5.2
Simple hysterectomy 88.4 83.5
Complex hysterectomy 8.5 11.3
Emergency case, % 0.6 2.8 <0.001
Diabetic on oral agents or insulin, % 7.1 8.5 0.010
Obesitya, % 44.0 46.4 0.020
Hypertension requiring medication, % 29.0 30.1 0.214
Currently on dialysis, % 0.1 0.2 0.034
Smoker during year prior, % 20.9 15.2 <0.001
Chronic obstructive pulmonary disease, % 1.4 1.4 0.787
Congestive heart failure, % 0.1 0.4 <0.001
Coronary artery diseaseb, % 1.5 1.8 0.248
Peripheral vascular diseasec, % 0.1 0.5 0.005
Cerebrovascular diseased, % 1.6 1.9 0.349
Bleeding disorder, % 0.8 2.5 <0.001
Cancere, % 1.2 3.5 <0.001
Pregnancy, % 0.0 0.3 <0.001
Prior operation within 30 days, % 0.4 1.0 <0.001
aBody mass index 30 kg/m2.
bMyocardial infarction in 6 months prior, previous percutaneous coronary intervention, or previous cardiac surgery.
cRequiring revascularization, angioplasty, or amputation.
dHistory of transient ischaemic attack or cerebrovascular accident with or without neurologic deﬁcit.
eChemotherapy or radiotherapy in 30 days prior, disseminated cancer, or tumor involving central nervous system.
doi:10.1371/journal.pone.0130861.t001
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excluded patients in the preoperative anaemia group and another including them in the no pre-
operative anaemia group. This would give out the two extremes of bias, in the case where
absence of preoperative HCT value was non-random.
All p-values were two sided with the level of significance set at 0.05. We carried out the data
management and analyses using the SAS software version 9.1 (SAS Institute Inc, Cary, NC).
Results
Data from 12,836 patients were included in this analysis. A total of 464 (3.6%) patients under-
went myomectomy, 11,193 (87.2%) had simple hysterectomy, while 1,179 (9.2%) had complex
hysterectomy. The mean age was 48.6 ± 12.1 years (range: 18–90 years). Based on the pre-set
(WHO) definition of anaemia, 3,071 patients had preoperative anaemia giving a prevalence of
23.9% (95% confidence interval [CI]: 23.2–24.7). Overall incidence of major comorbidities was
low in this population; cancer (1.2 & 3.5%), cardiac (1.6 & 2.2%) or renal failure (0.1 & 0.2%).
Anaemic patients were slightly younger (47 v 49), more likely to be non-white and less likely to
be smokers (Table 1).
Overall patients with preoperative anaemia had a significantly higher crude 30-day mortal-
ity (0.5% vs. 0.1%, p<0.001) and composite morbidity (5.1% vs. 2.5%, p<0.001) rates than
patients without preoperative anaemia (Fig 1). Preoperative anaemia was associated with sig-
nificantly higher rates of most evaluated 30-day postoperative outcomes (Fig 1). Preoperative
anaemia was associated with significantly higher rates probability of 30-day mortality and
Fig 1. Crude 30-day postoperative mortality andmorbidity rates in patients with and without preoperative anaemia. CNS, central nervous system.
doi:10.1371/journal.pone.0130861.g001
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composite morbidity. These probabilities continued to increase with declining HCT levels in
the preoperative anaemia group (Fig 2). After multivariate analysis adjusting for potential con-
founders, preoperative anaemia remained independently and significantly associated with
increased 30-day mortality and morbidity (Table 2). The ORadj-2 for death was 2.40 (95% CI:
1.06–5.44) in patients with preoperative anaemia compared to patients without. The ORadj-2
for composite morbidity was 1.80 (95% CI: 1.45–2.24) in patients with preoperative anaemia
compared to patients without. This was reflected by significantly higher adjusted odds of
almost all specific morbidities including respiratory, CNS, renal, wound, sepsis, and venous
thrombosis (Table 2). Although the adjusted odds of cardiac occurrences and major bleeding
were higher in patients with preoperative anaemia compared to patients without, they had
high uncertainty.
In the sensitivity analyses, results remained unchanged for both the primary and secondary
study outcome measures when patients with missing preoperative HCT levels (4%) were
included as either having anaemia or no anaemia.
The effect of perioperative transfusions
Patients with preoperative anaemia were more likely to receive perioperative transfusions than
patients without preoperative anaemia (9.2% vs. 1.5%, p<0.001). When the association
between preoperative anaemia and postoperative 30-day outcomes was further adjusted for
perioperative transfusion requirement, the effect estimates (OR) dropped by around 1 point
for mortality and by 0.3 points for composite morbidity (Table 3). In specific, the ORadj-2 for
mortality dropped from 2.40 to 1.49 meaning that around 61% of the observed increase in
30-day mortality due to preoperative anaemia is mediated by an increased requirement for
perioperative transfusion while the remaining effect is most likely attributed to an independent
effect. However, the ORadj-2 for composite morbidity dropped from 1.80 to 1.55 meaning that
only 16% of the observed increase in 30-day composite morbidity due to preoperative anaemia
is mediated by an increased requirement for perioperative transfusion while the remaining
effect is most likely due to an independent effect.
Discussion
Main findings
In a large series of patients these data show an independent association of preoperative anae-
mia with an increased risk of 30-day mortality and morbidity in females who underwent
gynaecological surgery. These effects were incremental with lower haematocrit levels, and were
still observed upon adjustment for the effects of patient characteristics, co-morbidities or type
of uterine surgery. Blood Transfusion did not appear to ameliorate these risks and may inde-
pendently be associated with increased risk of 30-day mortality and morbidity. These findings
carry important clinical implications, especially since around quarter of women presenting for
uterine surgery had with preoperative anaemia in this study.
Strengths and limitations
The key strengths of our study lie in the large number of patients and the reliable and compre-
hensive data collection tool of the ACS NSQIP, which provides an extensive list demographic,
pre-, and perioperative variables available for adjustment. These data present a homogenous
area of surgery in a relatively younger healthier population with a low incidence of cardiac or
respiratory disease compared to previous reports [12]. Our study carries several limitations:
Uterine surgery covers various indications, the incidence of cancer was very low (<4%) and
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Fig 2. Probability of (A) mortality and (B) composite morbidity according to descending hematocrit levels in the preoperative anaemia group.
doi:10.1371/journal.pone.0130861.g002
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the impact of preoperative anaemia in this subgroup could not be stratified due to small num-
bers, the majority of patients underwent simple hysterectomy we and did not distinguish
between open or laparoscopic techniques that may impact transfusion need. Approximately
2.5% of the preoperative HCT levels were obtained more than four weeks prior to surgery and
may not accurately reflect the HCT levels at the time of surgery. However, variation of HCT
levels in an individual is likely to be small in the absence of major bleeding, which in our data-
base would have been identified by preoperative blood transfusions and hence considered for
in the analysis looking at the effects or perioperative transfusions. Intraoperative nadir HCT or
immediate postoperative HCT levels are not documented in the ACS NSQIP. Thus, we were
unable to determine if lower intraoperative HCT was associated with worse outcomes.
The linkage to blood transfusion is associative. Blood transfusion is needed for blood loss
replacement in a time of haemodynamic need in surgery. However, indication for blood transfu-
sion is commonly based on HCT or haemoglobin levels rather than clinical indication and in the
stable patient, restrictive transfusion practise may not be routine in all centres. NSQIP does not
collect data on indication for transfusion so the associations presented cannot be fully explored.
The analysis used estimates the relative effects of anaemia and transfusion on outcomes.
Although causality between anaemia and transfusion is linked, the interplay with outcomes is
associative. Another potential limitation of this study was that we were unable to control for hos-
pital effects owing to the absence of hospital identifiers in our data. There may have been vari-
ability in hospital quality or variability in surgical strategy which may have potentially
confounded the association between risk factors and outcome. Finally, the possibility of residual
confounding is always present in observational studies such as that due to factors that we were
unable to account for (e.g., socioeconomic status, malnutrition, health consciousness).
Interpretation
Our study is in agreement with previous studies showing association of anaemia and adverse
outcome in patient undergoing surgery [5–8,10,12], and shows and independent association of
Table 2. Effects of preoperative anaemia on 30-day postoperative mortality andmorbidity.
Outcome Preoperative anaemiaa
ORunadj (95% CI) ORadj-1 (95% CI) ORadj-2 (95% CI)
Mortality 3.42 (1.65–7.09) 3.10 (1.46–6.54) 2.40 (1.06–5.44)
Composite morbidity 2.11 (1.72–2.59) 2.06 (1.67–2.53) 1.80 (1.45–2.24)
Speciﬁc morbidity
Cardiac 2.12 (0.76–6.00) 2.21 (0.77–6.33) 2.09 (0.69–6.33)
Respiratory 3.14 (2.08–4.75) 3.12 (2.05–4.76) 2.72 (1.75–4.23)
CNS 15.92 (1.86–136.34) 13.49 (1.55–117.4) 10.45 (1.05–103.90)
Renal 6.38 (2.57–15.83) 5.56 (2.22–13.96) 5.18 (1.94–13.86)
Wound 1.63 (1.20–2.21) 1.55 (1.14–2.10) 1.44 (1.05–1.98)
Sepsis 2.70 (1.86–3.91) 2.64 (1.81–3.86) 2.15 (1.45–3.20)
Venous thrombosis 2.28 (1.43–3.66) 2.24 (1.39–3.62) 1.96 (1.19–3.23)
Major bleeding 2.48 (1.23–4.99) 2.19 (1.08–4.43) 1.27 (0.58–2.81)
aPatients without preoperative anaemia constituted the reference population.
ORunadj = unadjusted odds ratio
ORadj-1 = adjusted odds ratio according to Model 1: adjusted for age, race, and type of uterine surgery.
ORadj-2 = adjusted odds ratio according to Model 2: adjusted for all variables in Table 1.
Abbreviations: CNS, central nervous system.
doi:10.1371/journal.pone.0130861.t002
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preoperative anaemia and adverse outcomes even in a younger and ‘fitter’ cohort of patients.
The relative contribution of preoperative anaemia and perioperative transfusions on postoper-
ative outcomes can be difficult to dissect. In our study, these data suggest that the effects of
anaemia on the risk mortality and less so, on the risk of morbidity may be partly attributed to
an increased requirement for transfusion use. It is not possible to link causality between either
preoperative anaemia and outcomes nor transfusion and outcomes. The question of whether
correction of anaemia improves these negative associative outcomes is the objective of several
ongoing clinical trials in Europe [25].
Nevertheless, recognition of anaemia and transfusion practice in surgery is vitally important
[2]. Patient Blood Management is an evidence-based approach to reduce risk from anaemia
and blood transfusion with direct impact on surgical patient outcomes. PBM focuses on three
‘pillars’ of care in the surgical patient: the detection and treatment of preoperative anaemia; the
reduction of perioperative blood loss; harnessing and optimising the patient specific physiolog-
ical reserve of anaemia, including restrictive haemoglobin transfusion triggers [26–28]. Patient
Blood Management has been adopted by the World Health Organisation, and recommenda-
tions have since been released for the implementation of PBM in the NHS [29].
Preoperative anaemia is readily and easily detectable and therefore a potentially preventable
risk factor in patients undergoing elective surgery [30]. It is recommended that haemoglobin/
haematocrit level determination is performed not less than 28 days before the scheduled elec-
tive surgical procedure, to allow for subsequent investigation and intervention in patients iden-
tified with anaemia [31]. At least, in orthopaedic [32] and cardiac [33] surgery, there is strong
evidence that preoperative treatment of anaemia results in reduced intraoperative pRBC trans-
fusion as well as improved outcome [34]. An additional approach in women due to undergo
uterine surgery, is to prevent heavy menstrual bleeding by the use of gonadotropin releasing
hormone analogues or ulipristal acetate [20].
Conclusion
Preoperative anaemia in women undergoing gynaecological surgery is an independent risk for
increased morbidity and mortality following surgery. Blood transfusion may not be correct this
Table 3. Effects of preoperative anaemia on 30-day postoperative mortality andmorbidity upon adjustment for perioperative transfusion
requirement.
Outcome Preoperative anaemiaa
No adjustment for perioperative transfusion Adjustment for perioperative transfusion
Mortality
ORunadj (95% CI) 3.42 (1.65–7.09) 1.90 (0.85–4.25)
ORadj-2 (95% CI) 3.10 (1.46–6.54) 2.13 (0.95–4.77)
ORadj-2 (95% CI) 2.40 (1.06–5.44) 1.49 (0.60–3.70)
Composite morbidity
ORunadj (95% CI) 2.11 (1.72–2.59) 1.67 (1.34–2.07)
ORadj-2 (95% CI) 2.06 (1.67–2.53) 1.71 (1.37–2.13)
ORadj-2 (95% CI) 1.80 (1.45–2.24) 1.55 (1.24–1.95)
aPatients without preoperative anaemia constituted the reference population.
ORunadj = unadjusted odds ratio
ORadj-1 = adjusted odds ratio according to Model 1: adjusted for age, race, and type of uterine surgery.
ORadj-2 = adjusted odds ratio according to Model 2: adjusted for all variables in Table 1.
doi:10.1371/journal.pone.0130861.t003
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risk. Further studies are needed to assess if the management of preoperative anaemia has an
impact on patient outcomes.
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